SUNITINIB MALATE

Generic: SUNITINIB MALATE

Novugen Pharma (USA) LLC.Manufacturer
ORALRoute
SUNITINIB MALATEActive Substance
2023-08-21Original Approval

SUNITINIB MALATE is FDA application ANDA218012, sponsored by FOSUN WANBANG. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DIARRHOEA
309 reports
2
DISEASE PROGRESSION
272 reports
3
DEATH
266 reports
4
FATIGUE
255 reports
5
VOMITING
249 reports
6
PLATELET COUNT DECREASED
238 reports
7
THROMBOCYTOPENIA
228 reports
8
NAUSEA
223 reports
9
ANAEMIA
201 reports
10
ASTHENIA
190 reports